Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Onco-Innovations Ltd. ( (TSE:ONCO) ) is now available.
Onco-Innovations Limited has appointed Jared Rushton to its Board of Directors, bringing over a decade of experience in public markets and strategic advisory across various sectors. This appointment is expected to enhance the company’s market positioning and operational execution. Additionally, the company has engaged MCS Market Communication Service GmbH for online marketing services, which will run until December 15, 2025, or until the budget is exhausted, aiming to boost its digital presence.
More about Onco-Innovations Ltd.
Onco-Innovations is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company is dedicated to the prevention and treatment of cancer through pioneering research and innovative solutions, and holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 39,885
Technical Sentiment Signal: Strong Sell
See more insights into ONCO stock on TipRanks’ Stock Analysis page.